Methadone: applied pharmacology and use as adjunctive treatment in chronic pain

R Brown, C Kraus, M Fleming, S Reddy, R Brown, C Kraus, M Fleming, S Reddy

Abstract

This article reviews the unique pharmacological properties of methadone and outlines its appropriate clinical application, with focus upon its use in the treatment of chronic pain. Although methadone is most widely known for its use in the treatment of opioid dependence, methadone also provides effective analgesia. Patients who experience inadequate pain relief or intolerable side effects with other opioids or who suffer from neuropathic pain may benefit from a transition to methadone as their analgesic agent. Adverse effects, particularly respiratory depression and death, make a fundamental knowledge of methadone's pharmacological properties essential to the provider considering methadone as analgesic therapy for a patient with chronic pain.

References

    1. J Addict Dis. 2001;20(2):55-73
    1. Eur Addict Res. 2000 Mar;6(1):8-19
    1. J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):153-60
    1. Clin Infect Dis. 2001 Nov 1;33(9):1595-7
    1. Ther Drug Monit. 2001 Oct;23(5):553-5
    1. Ther Drug Monit. 2002 Feb;24(1):26-31
    1. Clin Pharmacokinet. 2002;41(1):31-57
    1. J Clin Psychopharmacol. 2002 Apr;22(2):211-5
    1. Hematol Oncol Clin North Am. 2002 Jun;16(3):543-55
    1. Int J Androl. 1988 Apr;11(2):93-100
    1. Clin Pharmacokinet. 2002;41(14):1153-93
    1. Clin J Pain. 2002 Jul-Aug;18(4 Suppl):S3-13
    1. N Engl J Med. 1975 Apr 24;292(17):882-7
    1. J Pharmacol Exp Ther. 1975 Jan;192(1):211-17
    1. J Pharmacol Exp Ther. 1975 Nov;195(2):296-302
    1. Arch Gen Psychiatry. 1976 Jun;33(6):709-20
    1. NIDA Res Monogr. 1978;(19):142-8
    1. Int J Addict. 1979 Apr;14(3):329-35
    1. Lancet. 1979 Sep 8;2(8141):485-8
    1. Drug Alcohol Depend. 1981 Jun;7(3):249-56
    1. Acta Eur Fertil. 1985 Jul-Aug;16(4):245-9
    1. J Pain Symptom Manage. 1999 Oct;18(4):303-9
    1. Int J Clin Pharmacol Ther. 1999 Nov;37(11):562-6
    1. J Addict Dis. 1999;18(4):5-12
    1. Am J Psychiatry. 2000 Mar;157(3):481
    1. Addiction. 1999 Jul;94(7):961-72
    1. Am J Addict. 2000 Winter;9(1):63-9
    1. Mt Sinai J Med. 2000 Oct-Nov;67(5-6):365-74
    1. Lancet. 2000 Dec 16;356(9247):2069-70
    1. Med J Aust. 2000 Nov 20;173(10):536-40
    1. Br J Clin Pharmacol. 2001 Mar;51(3):213-7
    1. J Pain Symptom Manage. 1990 Feb;5(1):1-5
    1. Int J Addict. 1992 Nov;27(11):1325-34
    1. Ann Intern Med. 1993 Jul 1;119(1):23-7
    1. Cancer. 1993 Oct 1;72(7):2266-72
    1. Palliat Med. 1994;8(2):153-5
    1. J Consult Clin Psychol. 1995 Feb;63(1):158-62
    1. J Pain Symptom Manage. 1996 May;11(5):321-8
    1. Cancer. 1996 Aug 15;78(4):852-7
    1. J Clin Oncol. 1996 Oct;14(10):2836-42
    1. BMJ. 1996 Oct 12;313(7062):925-6
    1. Ther Drug Monit. 1996 Oct;18(5):570-2
    1. Drug Metab Dispos. 1998 Mar;26(3):257-60
    1. Addiction. 1997 Nov;92(11):1445-55
    1. Clin Pharmacol Ther. 1998 Jun;63(6):655-62
    1. J Clin Oncol. 1998 Oct;16(10):3216-21
    1. J Clin Pharmacol. 1998 Oct;38(10):931-5
    1. Schweiz Med Wochenschr. 1998 Oct 10;128(41):1538-47
    1. Subst Use Misuse. 1998 Dec;33(14):2819-34
    1. Lancet. 1999 Jan 16;353(9148):221-6
    1. J Subst Abuse Treat. 1999 Mar;16(2):113-21
    1. Aust N Z J Psychiatry. 1999 Feb;33(1):99-101
    1. AIDS. 1999 May 28;13(8):957-62
    1. J Clin Oncol. 2001 Jun 1;19(11):2898-904

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться